ARG1 and cancer: In contrast, interstitial MΦs of tumours treated with either RMC-4998 or RMC-4550 had reduced ARG1 expression, suggesting that cancer-cell MAPK pathway inhibition hindered immunosuppressive properties of interstitial MΦs (Fig. 5c, d and Supplementary Fig. 5b).